71 results
Page 4 of 4
424B5
sh2iow6t uokqz
19 Feb 19
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
whae5g d6v
19 Feb 19
Results of Operations and Financial Condition
4:01pm
8-K
EX-99.1
pfo5zs d4yi9rm
7 Jan 19
Regulation FD Disclosure
6:31am
8-K
EX-99.1
zz1 fpw7w
4 Jan 19
Other Events
8:03am
8-K
EX-99.1
qgop1ffc
6 Dec 18
Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
8:05am
S-3
EX-1.2
fbjdfcg5
1 Jun 18
Shelf registration
5:14pm
S-3
EX-4.4
dvmrlr2 m6o
1 Jun 18
Shelf registration
5:14pm
10-K
6pndoe7e
29 Mar 18
Annual report
12:00am
10-K
EX-10.19
mczsna
29 Mar 18
Annual report
12:00am